Polycystic Kidney Diseases - 18 Studies Found

Completed : Polycystic Kidney Disease Data Repository
: Polycystic Kidney Disease
: 2008-11-14
Withdrawn : Repository Study of Autosomal Dominant Polycystic Kidney Disease
: Autosomal Dominant Polycystic Kidney Disease
: 2013-11-07
Completed : Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
: Polycystic Kidney Disease
: 2014-05-14
: Dietary Supplement: Niacinamide Other Name: Vitamin B3
Completed : Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: Polycystic Kidney Diseases
: 2006-02-01
: Drug: Rapamune Group 1- doses of Rapamune aimed at maintaining trough levels 5-8ng/ml Group 2 - doses of
Completed : Lanreotide In Polycystic Kidney Disease Study
: Autosomal Dominant Polycystic Kidney Disease (ADPKD
: 2014-04-02
:
  • Drug: Lanreotide 120 mg, subcu
Completed : Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
: Autosomal Dominant Polycystic Kidney Disease
: 2007-12-31
: Drug: Tetracosactin 1 microgram tetracosactin, intravenous injection, once for the test
Enrolling by invitation : Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
: Autosomal Dominant Polycystic Kidney Disease
: 2009-12-23
Completed : 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: Autosomal Dominant Polycystic Kidney Disease
: 2011-10-11
:
  • Drug: Tolvaptan MR 50/80 mg ca
Completed : Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
: Autosomal Dominant Polycystic Kidney Disease
: 2006-12-20
:
  • Drug: Placebo placebo comparat
Active, not recruiting : Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
: Autosomal Dominant Polycystic Kidney Disease
: 2011-06-20
:
  • Drug: Octreotide-LAR 40 mg eve
Next >>>